Registration and Activity Links - GROWTH DISORDERS
|
|||
|
|||
Medical Management of Children Born SGA: A Team Approach
A special Web-based presentation on the diagnosis and medical management of children born small for gestational age (SGA) took place on Thursday, November 20, 2003. This CME/CE activity has expired and is no longer available for viewing.
The program featured an actual case followed from initial assessment through successful treatment and included electronic polling questions and an interactive Q&A session with the faculty.
The program is available for viewing online at www.sga.ncme.com.
Faculty
Program Description
Learning Objectives
Program Rationale
Credit Designations
Faculty
Pinchas Cohen, MD
Professor and Director of Research and Training
Department of Pediatrics
Division of Endocrinology
Mattel Children’s Hospital
University of California at Los Angeles
Los Angeles, California
Peter A. Lee, MD, PhD
Penn State Children’s Hospital
Department of Pediatrics
Pennsylvania State University College of Medicine
Hershey, Pennsylvania
William B. Zipf, MD
Medical Director
Central Ohio Pediatric Endocrinology and Diabetes Services
Clinical Professor of Pediatrics
The Ohio State University College of Medicine and Public Health
Columbus, Ohio
Nurse Advisor
Belinda Pinyerd, PhD, RN
Pediatric Endocrinology Nurse
Columbus, Ohio
Program Description
Leading experts in diagnosing and managing growth failure in children will discuss:
• How to evaluate whether a child is born small for gestational age (SGA)
• Which children born SGA should be referred for further evaluation and for growth hormone (GH) therapy
• When and how long to treat children who are born SGA with GH therapy
• How to monitor the effects of GH therapy
The distinguished faculty also will address potential growth and nongrowth consequences of SGA, and appropriate intervention and safety considerations associated with GH treatment of children of short stature who are born SGA.
Learning Objectives
After taking part in this activity, the participant should be able to:
• List the causes of SGA
• Describe how to perform a standard evaluation for short stature in a child who is born SGA
• Identify which children born SGA should be referred to a pediatric endocrinologist for further evaluation
• Define potential growth and nongrowth consequences of being born SGA
• Discuss optimal dosing and duration of growth hormone (GH) therapy in short children born SGA, and explain how to monitor children on GH therapy for clinical efficacy and potential adverse effects
Target Audience
This activity is designed for general pediatricians, pediatric endocrinologists, pediatric endocrinology nurses, and other health care professionals involved in the diagnosis, treatment, and management of children who are born small for gestational age.
Program Rationale
The majority of children born small for gestational age (SGA) will experience adequate catch-up growth in length during the first 2 years of life. However, 1 in 10 will not catch up and will remain short as adults. Children born SGA are at risk for a number of medical consequences, including poor growth in childhood, shorter adult stature, and cognitive and neurodevelopmental impairment. Low birth weight also has been associated with hypertension, type 2 diabetes, and cardiovascular disease in adulthood.
Fortunately, effective techniques have been developed to identify children who are born SGA, and treatment with growth hormone has been found to be safe and effective in improving growth in short children born SGA.
To have a chance to achieve catch-up growth in early childhood, maintain normal growth, and reach normal adult height, children born SGA need to be diagnosed and treated as early as possible. Pediatricians can play a crucial role in identifying children older than 2 to 3 years of age who are SGA and have persistent short stature, and referring them to pediatricians with expertise in endocrinology for further evaluation and treatment. Working together as members of the pediatric health care team, pediatricians, nurses, and pediatric endocrinologists can help ensure that children born SGA have the opportunity to reach their full height potential and live healthier and more satisfying lives.
Accreditation and Credit Designations
This CME/CE activity has been planned and developed by the Network for Continuing Medical Education (NCME).
NCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NCME designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.
This program for 1.0 contact hour is provided by the National Center for Advanced Medical Education, which is accredited as a provider of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is supported by an educational grant from Pfizer Inc.